Rezultati
eNauka >
Rezultati >
P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling
| Naziv: | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling | Autori: | Đoković, Nemanja   ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Beljkaš, Milan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Oljačić, Slavica ; Nikolić, Katarina |
Godina: | 2025 | Publikacija: | Oncology Insights: Official Journal of the Serbian Association for Cancer Research. The 1st Regional SDIR-HDIR-MOKAD Congress, October 8-10, 2025, Belgrade, PROCEEDINGS BOOK | ISSN: | 3009-3848 Oncology Insights Pretraži identifikator |
Izdavač: | Belgrade : Serbian Associaon for Cancer Research. SDIR Zagreb : Croatian Association for Cancer Research. HDIR Molecular Cancer Research Association MOKAD |
Tip rezultata: | Konferencijski rad | Kolacija: | br. 3 str. 85-85 Session 1. BENEFITS OF COMBINATION THERAPIES IN CANCER TREATMENT | VBS COBISS  : | 125366281 | URI: | https://farfar.pharmacy.bg.ac.rs/handle/123456789/6282 https://enauka.gov.rs/handle/123456789/1004450 |
URL: | https://www.sdir.ac.rs/pdf/Abstract%20Book%20-%20SDIR-7.pdf#page=86.00 | Projekat: | Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200161 (Univerzitet u Beogradu, Farmaceutski fakultet) (RS-MESTD-inst-2020-200161) COST Actions CA18240, CA21135 and CA22125 of the European Community |
M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Google ScholarTM
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.